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Multiple myeloma (MM) is a B-cell neoplasm, mainly character-
ized by the monoclonal expansion of plasma cells, the presence of
monoclonal serum immunoglobulin and the occurrence of osteo-
lysis. The malignant cell corresponds to a long-lived plasma cell
located in the bone marrow (BM) carrying somatically rearranged
Ig genes with clonally fixed hypervariable regions (Bakkus 
et al, 1992; Hallek et al, 1998). This implies a post-germinal centre
origin of the MM cells (Bakkus et al, 1992) having a specific
migration to the extravascular compartment of the BM. This
process of migration of MM cells to the extravascular compart-
ment of the BM, and referred to as ‘homing’, is believed to be
highly specific since no elevated quantity of malignant B-cells are
observed in the peripheral blood or in other organs. After their
specific homing to the BM, these cells proliferate and differentiate
into mature plasma cells. It is only at the endstage of the disease of
some patients that extramedullar spread is observed.
In our previous work we have reported the 5T2MM model in
the C57BL/KaLwRij mice (Radl et al, 1979) as a good model 
to study the homing of human myeloma cells in the BM
(Vanderkerken et al, 1996, 1997). In this model, MM cells are
isolated from diseased animals and are transplanted into young
syngeneic recipients by intravenous injection. From 9 weeks on
after injection we observe a specific localization of the MM cells
in the BM and partly in the spleen of the mice. This study did not,
however, reveal whether this selective localization of MM cells in
the BM is due to a selective initial entry of the cells through the
endothelial barrier of the BM, or whether this homing is more
random, and survival and growth factors, only present in BM,
determine the unique presence of MM cells.
The migration of lymphocytes in general (Butcher and Picker,
1996) is known to include a multistep cascade of processes mainly
involving the endothelium. This interaction with the endothelium
requires at least four independent steps: initial tethering, arrest,
adhesion and transendothelial migration. It is the combination of
the selectivity of each independent step which makes the process
highly specific. In vivo, BM endothelial cells (BM EC) act as 
gate-keepers separating the BM compartment from the sinusoidal
lumen. These cells may therefore play an important role in the
selective entry of the MM cells.
We conclude here that MM cells have a selective homing behav-
iour which is the result of the combination of a selective adhesion
to the BM EC followed by the entry in the extravascular compart-
ment and a selective survival and growth, making the BM and
spleen microenvironment unique.
MATERIALS AND METHODS
Mice
C57BL/KaLwRijHsd mice (Harlan CPB Zeist, The Netherlands)
were housed under conventional conditions and had free access to
tap water and food. They were anaesthetized by intraperitoneal
(i.p.) injection of 200 ml Imalgene (80 mg kg–1 body weight;
Rhône Merieux, Lyon, France) and Rompoun mixture (10 mg kg–1
body weight; Bayer, Sint-Truiden, Belgium). Mice were killed by
carbon dioxide asphyxiation. Licence number LA1230281.
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The 5TMM lines originated spontaneously in ageing
C57BL/KaLwRij mice as described previously (Radl et al, 1979).
For the preparation of the cells, BM was flushed from the hind legs.
Cells were purified by gradient centrifugation on Lympholyte M
(Cedarlane, Hornby, Ontario, Canada) at 450 g for 25 min, washed
and further purified by a Percoll (Pharmacia AB, Uppsala, Sweden)
60% gradient centrifugation at 500 g for 25 min. Purity was
assessed by FACS-staining with 5T2MM anti-idiotype-specific
antibodies as described previously (Vanderkerken et al, 1997).
Injection of the chromium-51 labelled 5T2MM cells
5T2MM cells were prepared as described above and incubated for
80 min at 37°C with 150 mCi chromium-51 (Amersham, Gent,
Belgium) for 6 ´ 106 cells. After washing, cell viability was
assessed by trypan blue exclusion and 2 ´ 106 viable cells were
injected intravenously (i.v.) (tail vein). After 1, 2 and 18 h mice
were sacrificed, blood and urine collected, and the legs, ribs, verte-
brae, intestines, kidneys, testes, liver, lungs and heart removed.
Following rinsing abundantly in phosphate-buffered saline (PBS)
and weighing, the radioactivity of the different organs was
assessed in a g-counter (MR480C/TP ITM, Van Hopplynus,
Brussels, Belgium). Results are presented as the percentage of
total recovered radioactivity.
Selective elimination of Kupffer cells in vivo
Kupffer cells (KC) were eliminated in vivo by the ‘liposome medi-
ated macrophage suicide’ technique (Van Rooijen, 1989). With
this technique, liposomes are phagocytosed by the macrophages,
followed by disruption of the phospholipid bilayers of the
liposomes under the influence of lysosomal phospholipases. As 
a result, clodronate accumulates intracellularly and causes
irreversible damage to the macrophages followed by killing of 
these cells. Non-phagocytic cells are not affected by this method.
Then, 0.1 ml of liposomes encapsulating the toxic compound
dichloromethylene-diphosphonate (Cl2MDP) were injected i.p. 
24 h before the experiment. The liposomes were kindly donated by
Dr N Van Rooijen (Free University Amsterdam, The Netherlands).
Quantitation of KCs in sections
Newly sacrificed mice were subjected to a preperfusion with PBS
through the portal vein, followed by perfusion fixation with 1.5%
glutaraldehyde in 0.14 M cacaodylate during 4 min at a rate of 
4 ml min–1. Blocks of liver were cut with a vibratome and rinsed in
PBS at 4°C, followed by incubation in peroxidase-medium (0.1 %
diaminobenzidine-hydrochloride and 0.02% hydrogen peroxide in
0.1 M PBS, pH 6.9) for 60 min. This was followed by osmium
fixation and epon-embedding before ultrathin sectioning. The
presence of endogenous peroxidase-positive KC was analyzed by
transmission electron microscopy (Philips EM 400, Eindhoven,
The Netherlands).
Isolation and culture of liver non-parenchymal and
endothelial cells
Liver endothelial cells (LEC) and non-parenchymal cells (LEC
plus KCs) were isolated essentially as described by Smedsrod and
Pertoft (1985). Briefly, the portal vein was perfused with Ca-free
buffer (‘perfusion buffer’) followed by 0.05% collagenase
(Boehringer Mannheim, Scandinavia) in 1% bovine serum
albumin (BSA). The resulting cell suspension was washed at 
53 g (2 min) to remove parenchymal cells. The supernatant was
centrifuged at 1316 g (10 min) and cells resuspended in perfusion
buffer containing 1% BSA followed by centrifugation through a
discontinuous Percoll gradient consisting of 20 ml 50% Percoll
and 18 ml 25% Percoll (1316 g for 30 min). Cells banding at the
25–50% Percoll interface were washed once with perfusion buffer
and the pellet was resuspended in RPMI-1640. Non-parenchymal
cells were cultured on 24-well tissue plates (Falcon) precoated
with human serum fibronectin (0.3 mg ml–1 in PBS, 2 mM EDTA,
0.02% azide, a gift from Berit Hansen, University of Tromso), at a
density of 1.5 ´ 106 cells well–1 in 0.5 ml. After 45-min incubation,
monolayers were washed three times and incubation was continued
in 0.5 ml RPMI-1640 for 2–3 h.
To obtain purified cultures from LEC, non-parenchymal cells
were seeded in NUNC dishes (56.7 cm2, NUNC, Heigar, Oslo,
Norway). Following incubation at 37°C for 20 min, non-adherent
cells (LEC) were collected and seeded in 24-well tissue culture
plates precoated with fibronectin. After 45-min incubation, the
adherent cells were washed three times with PBS and incubated
with 0.5 ml RPMI-1640 for 2–3 h before use.
Bone marrow and lung endothelial cell lines
STR-4, STR-10, STR-12, murine bone marrow EC lines and
LEISVO, a lung EC line were used. All lines were previously
established by transfecting primary EC cultures with SV40 (Imai
et al, 1999) and were maintained in culture in RPMI-1640 
(Gibco, Life Technologies, Gent, Belgium) supplemented with
penicillin–streptomycin, glutamine and MEM (Gibco) and 10%
bovine serum (Fetal Clone I, Hyclone, UT, USA).
Adhesion assay
5T2 MM cells (with an average purity of 90%) were labelled with
51Cr, as described above. Then, 3 ´ 1055 1 Cr labelled tumoral cells
were added (0.5 ml of cell suspension per well) to monolayers of
freshly isolated LEC or non-parenchymal cells and to BM EC
(STR-4, STR-10, STR-12) and lung EC (LEISVO) lines and were
incubated for 1 h at 37°C. Supernatant was removed and the cells
washed carefully with 0.5 ml of warm PBS. Cell lysates of the
adherent cells were obtained by adding 1% sodium dodecyl
sulphate (SDS) solution. Radioactivity was assessed in a 
g-counter. The percentage adhesion was calculated as follows:
Liver digestion
After sacrifice, the liver was preperfused through the vena porta
with Gey’s balanced salt solution (GBSS) at 37°C for 5 min. 
This was followed by a perfusion of GBSS supplemented with 
7.8 ´ 10–4 M Ca2+ containing 0.012% collagenase-P (Boehringer,
Brussels, Belgium), 0.20% pronase E (Merck, Overijse, Belgium)
and 0.01% DNAase-I (Boehringer) for 30 min at 37°C. During
this digestion the liver was kept warm with infra-red light. After
perfusion, the liver was removed, dispersed and homogenized in a
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mixture of GBSS with Ca2+, 0.005% collagenase-P, 0.025%
pronase E and 0.001% DNAase-I. Digestion was continued by
shaking at 37°C. After centrifugation, cell suspension was filtered
through a nylon gauze with 106 mesh.
Immunogold silver staining on cytospins
Immunogold silver staining was performed with the specific 
anti-5T2MM idiotype antibodies as described previously
(Vanderkerken et al, 1997). Briefly, cytospins of the cell suspen-
sions were prepared at a density of 4 ´ 105 cells ml–1. The dried
cytospins were incubated with a mouse anti-5T2 idiotype antibody
(IgG1, 3 mg ml–1) for 30 min, followed by rinsing and an incuba-
tion with gold-labelled goat-anti mouse IgG1 antibody (Auroprobe
LM, Amersham International, UK) at a dilution of 1:75 for another
30 min. After rinsing, a silver enhancement was performed 
with the Intense B1 Silver Enhancement kit (British Biocall
International, Sanvertech, Cardiff, UK) for 15 min at 26°C
followed by counterstaining with May–Grünwald–Giemsa.
Irrelevant isotype-matched antibodies were used as a control for
the first step.
FACS analysis
Purity of 5T2MM cells was measured by indirect FACS staining.
Hereby, 2.5 ´ 105 cells were incubated with biotinylated anti-
5T2MM (Vanderkerken et al, 1997) or isotype matched control
antibodies for 30 min at 4°C. Streptavidin–phycoerythrin
(Pharmingen, San Diego, CA, USA) was used as a second step.
After each incubation cells were washed twice with PBS supple-
mented with 1% BSA and 0.02% sodium azide. Cells were fixed
in 2% paraformaldehyde after the final washing step and analyzed
with a FACSort flowcytometer (Beckton Dickinson, Mountain
View, CA, USA). Data of 10 000 events were acquired and stored
in list moded files. FACS analysis was performed with LYSIS II
software (Beckton Dickinson).
Nucleic acid preparations
Using TRIzol reagent (Gibco, Life Technologies) total RNA and
DNA were extracted from crushed tissue from the BM, lungs,
liver, heart, spleen, intestines, kidneys and testis. Two micrograms
of total RNA were converted into firststrand cDNA using the
Superscript Preamplification System (Gibco, Life Technologies).
For each PCR firststrand cDNA corresponding to 50 ng RNA was
used.
PCR analysis
For the detection of the 5T2 VH sequences (Zhu et al, 1998) a PCR
was performed making use of an antisense FR4 primer (5¢-
GGGGGATCCTGCAGAGACAGTGACCAGAGT) in combina-
tion with a sense FR1 primer (5¢-GGGGGATCCACAGATCCAG-
TTGGTGCAGT) in a 25 ml reaction containing: 2 mM magnesium
chloride, 0.2 mM dNTP, 0.6 mM of each primer and 1.25 U Taq
polymerase (Gibco, Life Technologies). Forty PCR cycles were
applied after a 5 min incubation at 94°C with the following steps:
30 s at 94°C, 30 s at 55°C and 30 s at 72°C.
To increase the sensitivity of detection, 10 ml of the PCR mixture
was subjected to electrophoresis through a 1.5% agarose/TBE gel,
transferred and cross-linked to a nylon membrane (Fluka, Sigma).
The filters were hybridized to an internal 32P-end labelled CDR3
oligonucleotide in 6 ´ SSC (saline-sodium citrate), 1% SDS, 2.5 ´
Denhardt’s solution and 0.5 ´ Ppi for 4 h at 42°C. Post-hybridiza-
tion washes were performed in 2 ´ SSC/0.1% SDS at 42°C.
In order to assess the sensitivity of our PCR strategy to detect
5T2MM cells in different invaded organs (bone marrow, liver and
spleen), tumour cells were serially diluted in bone marrow, spleen
cells and hepatocytes (isolation as described above) with a factor
of 3.16 and pelleted. Uzing Trizol reagent the RNA was extracted
from the cell pellets and a one-step RT-PCR was performed using
the Titan™ One Tube RT-PCR System (Boehringer Mannheim,
Roche, Switzerland) with the same primers as described above.
The analysis of the amplification products and the hybridization
with the 5T2MM-specific oligonucleotides were performed as
described.
Statistical analysis
Results are given as the mean and standard deviation. The
unpaired Student’s t-test was used. P-values < 0.05 were consid-
ered as statistically significant.
RESULTS
Injection of radiolabelled cells
The immediate homing of the 51Cr-labelled 5T2MM cells was
assessed by monitoring the radioactivity of the different organs
(Figure 1). One hour after injection radioactivity was observed in
liver, lungs, BM and kidney. During the experiment (2–18 h) the
radioactivity increased in BM, liver and spleen and decreased in
the lungs. The radioactivity of 50 ml heparanized blood was
extrapolated to 2 ml blood and contained an average of 4.9% of
total radioactivity recovered. Radioactivity observed in the
kidneys throughout the experiment could be explained by secre-
tion of spontaneously released 51Cr in the urine (significant
amounts present, data not illustrated).
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Figure 1 Radioactivity of different organs 1, 2 and 18 h after intravenous
injection of 51Cr-labelled 5T2MM cells. Each bar represents the mean and
standard deviation of four mice. BM represents the radioactivity of ribs,
vertebrae and fore and hind legsElimination of KCs
Radioactivity observed in the liver (Figure 1) could be due to
phagocytosis of 51Cr-labelled 5T2MM cells by KCs, the liver resi-
dent macrophages. To investigate this possibility KCs were elimi-
nated prior to injection of the labelled 5T2MM cells by injection
of liposomes encapsulating the toxic compound Cl2DMP. As a
control for the elimination of the KCs, mice were sacrificed and
KCs were stained by endogenous peroxidase staining (Figure 2). A
total disappearance of the KCs was observed in the treated mice
when compared to control mice (data not shown). When 51Cr-
labelled 5T2MM labelled cells were injected in Cl2DMP-treated
mice liver radioactivity decreased by 70, 60 and 42% respectively
1, 2 and 18 h after injection (Figure 3). All differences were statis-
tically significant (P < 0.05).
Adhesion assay
Adhesion assays of 5T2MM cells to monolayers of bone marrow-
derived EC lines (STR4, STR10 and STR12) and freshly isolated
liver EC revealed an adhesion between 30 and 50% while almost
no adhesion (7%) was observed to lung-derived EC. The adhesion
to liver EC was increased by more than 10% when KCs and EC
together made up the monolayer (Figure 4).
Immunostaining of cells isolated from liver, BM and
spleen
To confirm the results obtained with radioactive cells, mononuclear
cells were prepared from BM and spleen 18 h after the injection of
the non-radioactive 5T2MM cells. Liver was digested enzymatically
(collagenase/pronase) and cells were enriched by Lympholyte M and
Percoll 60% gradient centrifugation. For BM and spleen respectively
0.8% ± 0.3 (mean ± standard deviation of three independent experi-
ments) and 1.4% ± 0.4 of 5T2 idiotype-positive MM cells were
observed by FACS analysis. Since the liver suspension contains a
high proportion of autofluorescent cells which interfere with the
detection of the small proportion of 5T2MM cells present, cytospins
were prepared of the enriched cell suspension and immunogold-
silver staining was performed. Figure 5 illustrates a 5T2MM-positive
cell present in liver suspension. A mean of 3.2% ± 1.4 positive cells
were detected, with all irrelevant control antibodies being negative.
956 K Vanderkerken et al
British Journal of Cancer (2000) 82(4), 953–959 © 2000 Cancer Research Campaign
Figure 2 Electron micrograph illustrating a Kupffer cell stained for
endogenous peroxidase. Bar = 1 mm
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Figure 3 Decrease in radioactivity after pretreatment of the mice with
Cl2DMP. Each bar represents the mean and standard deviation of four mice
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Figure 4 Adhesion of 5TMM cells to bone marrow endothelial cell lines
(STR4, STR10, STR12), lung endothelial cells and freshly isolated liver
endothelial cells, with (EC + KC) and without the presence of Kupffer cells
(EC). Results represent mean and standard deviation of three independent
experiments. The difference between LEC + KC and LEC is statistically
significant (P < 0.002)
Figure 5 Micrograph illustrating a 5T2MM idiotype-positive cell in a liver
suspension, 18 h after injection. Bar = 10 mmImmediate homing of 5T2MM cells 957
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Detection of 5T2 sequences in different organs using a
PCR-based strategy
Using a sensitive PCR strategy, BM, lungs, liver, heart, spleen,
intestines, kidney and testes were screened for the presence of
tumour cells 18 h after i.v. injection. After extraction of RNA from
the different (intact) organs a RT-PCR was performed to amplify
part of the tumoural VH sequence. To increase the sensitivity as
well as the specificity of detection, the amplification products
obtained were hybridized with the 5T2MM-specific internal
CDR3 probe. 
Figure 6 illustrates the results of this screening. While the control
PCR (Figure 6A) shows an adequate quality of the first strand
cDNAs used, the presence of tumoural sequences was shown to be
restricted to the samples derived from the BM and the spleen
(Figure 6B). Since in the previous experiments the presence of
5T2MM cells had been demonstrated in BM, spleen and liver, the
5T2MM-specific PCR was performed on cDNA (RNA) from
5T2MM cells serially diluted in cells prepared from the organs
mentioned above. For BM and spleen we were still able to obtain
tumour-specific amplification products in a dilution of 1 tumour
cell in 106 normal organ-derived cells. In the liver dilution,
however, no 5T2 specific sequences could be demonstrated in 
the samples containing dilutions beyond 1 tumour cell per 3160
hepatocytes (Figure 7).
DISCUSSION
MM represents a B-cell malignancy characterized by the presence
of a monoclonal population of end-stage B-cells in the BM.
Although fully matured BM plasma cells are the predominant cell
type in MM, there is much evidence that more immature B-cells
are also included in the malignant clone (Bakkus et al, 1992; Van
Riet, 1989). The fact that these cells, which are considered to be
myeloma precursor cells, are detectable in the blood circulation
and that their numbers increase with disease progression makes it
very likely that they represent the component that mediates disease
progression (Pope et al, 1997).
Although the organ-specific occurrence of cancers and their
metastases have been recognized for more than a century, the exact
mechanisms have not yet been elucidated. One of the earliest
hypotheses was the ‘seed and soil’ hypothesis whereby particular
tumour cells (‘seeds’) find organs with a suitable microenvironment
(‘soil’) for survival and growth. Since plasmablasts or plasmacytic
cells migrate from the blood to the extravascular compartment of the
BM it can be assumed that MM cells, which are derived from
normal B-cells, have an important part of their migration and
homing programme in common with their normal counterparts. The
restricted localization of MM cells in the BM, during the initial stage
of the disease, could be explained by such a selective migration of
the circulating MM cells to the BM and/or by the presence of a
unique local microenvironment supporting the survival and growth
of the tumoural cells which is not present at extramedullary sites. It
is well established that the growth regulation of myeloma cells in the
BM compartment is regulated by a functional interplay between the
tumour cells and the surrounding stroma involving the action of
several cytokines, adhesion molecules and metalloproteinases (Van
Riet et al, 1998, review). However, very little is known about the
migration behaviour of the MM cells. The purpose of this work was
to determine whether the selective localization of MM cells in the
BM is due to such a selective homing process, or whether the
homing to tissues is more random.
In the first series of experiments the initial distribution of the
5T2MM cells was determined after i.v. injection of radioactively
labelled cells. Shortly (1 h) after injection, lungs, liver, BM and
spleen were positive. Radioactivity of the lungs decreased in time
and was almost completely lost by 18 h. The initial elevated
radioactivity of the lungs can be explained by a mechanical
MB M L uL iH a S pI n K iT e
A
B
Figure 6 Amplification with actin primers (A) and with 5T2MM-specific
primers followed by hybridizations of the PCR-products with the CDR3 
probe (B) The analysis was performed on first strand cDNA extracted from
the following organs: BM (BM), lungs (Lu), liver (Li), heart (Ha), spleen (Sp),
intestines (In), kidney (Ki), testis (Te)
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Figure 7 One step RT-PCR with 5T2MM-specific primers on RNA from
5T2MM cells serially diluted in normal bone marrow, liver and spleen cells
and subsequent hybridization of the amplification products with the CDR3
probetrapping of the MM cells in the lungs, since after intravenous
injection the lungs represent the first vascular bed encountered.
Our adhesion assay confirmed that there was only little stable
adhesion to lung EC. During the entire experiment (1, 2 and 18 h)
the majority of the radioactivity was found in the liver. When a
similar experiment was performed for 5T33MM cells, an analo-
gous organ distribution pattern was observed (manuscript in
preparation). High liver radioactivity was not due to uptake of
released radio-isotope since it is known that sodium chromate
(Na2
51CrO4) is taken up by living cells in the hexavalent form and
is released from lysed cells in the trivalent form, which is not reuti-
lized (Coligan et al, 1984). Another possible explanation for the
high radioactivity in the liver was the phagocytosis of labelled
5T2MM cells by KCs, the hepatic resident macrophages. To
examine this possibility, KCs were depleted selectively in vivo by
the administration of liposome encapsulated clodronate (Van
Rooijen, 1989, 1996) prior to injection of the labelled 5T2MM
cells, resulting in a decreased accumulation of radioactivity in the
liver. This could be partially explained by the adhesion assays
which demonstrate an enhanced adhesion of 5T2MM cells to liver
endothelium in the presence of KCs and partially by phagocytosis
of death labelled tumoural cells.
As a confirmation of the first series of experiments BM, spleen
and liver cells were isolated 18 h after injection of the 5T2MM
cells and analyzed for the presence of 5T2MM idiotype-positive
cells. FACS analysis showed 5T2MM-positive cells in BM and
spleen samples, while gold-silver staining on cytospins demon-
strated 5T2MM-positive cells in the hepatic cells. As a second
confirmation for the selective presence of the MM cells, different
organs were removed 18 h after injection of the tumour cells, RNA
was prepared and a PCR was performed amplifying specific
5T2MM sequences. These data showed a 5T2MM-specific ampli-
fication product in BM and spleen and not in liver. Since the
negativity of the liver was clearly in contrast to the previous exper-
iments, the sensitivity level to detect 5T2 sequences via PCR was
compared. Therefore 5T2MM cells were serially diluted in BM,
spleen cells and hepatocytes with a factor of 3.16. Applying the
PCR strategy described above with a subsequent hybridization of
the amplification products, we show a more limited 5T2MM-
detection in the liver with a factor of at least 300 when compared
to BM and spleen. A likely explanation for this limited sensitivity
might be the high RNA content of hepatocytes (De Bleser et al,
1997) when compared to other cells. Another explanation for the
discrepancy between the different experiments is the size of the
organ. In the liver, the 5T2MM cells are diluted in a higher number
of cells when compared to BM and spleen. Moreover, it is likely
that the MM cells in the liver are not viable since no growth of
MM cells was observed in diseased mice (Vanderkerken et al,
1997). Therefore, it is plausible that the MM cells which were
trapped mechanically in the liver sinusoids adhere to the hepatic
sinusoidal EC but do not survive. The adherence to hepatic EC
could be mimicked by in vitro adhesion assays. These results are
in agreement with other reports: both activated and memory cells
(Smith and Ford, 1983; Jaeschke and Smith, 1997; Tietz and
Hamann, 1997; Salmi et al, 1998) and lymphoma cells (Aoudjit 
et al, 1998; Jonas et al, 1998) display a high affinity for the liver.
Moreover IGF-1, which is abundantly secreted in liver and BM, is
a chemotactic factor for 5T2MM cells (Vanderkerken et al, 1999)
and 5T33MM cells (manuscript in preparation). Although both
5T2 and 5T33MM cells have a similar initial distribution pattern,
these cells have a different organ distribution in diseased mice
(Vanderkerken et al, 1997). While the 5T2MM cells were only
found in BM and part of the spleens of the diseased mice,
5T33MM cells also grow in the liver. One hypothesis for this
differential growth in the liver could be a post-homing event,
being the differential responsiveness of the 5T2MM cells to the
mitogenic stimulus of IGF-1 (no proliferation observed,
Vanderkerken et al, 1999) in contrast to 5T33MM cells (prolifera-
tion observed, manuscript in preparation). Around mid-gestation,
haematopoietic progenitors are thought to migrate in the blood-
stream to colonize the liver. At birth the BM becomes the main site
for haematopoiesis and remains so throughout adult life. A hier-
archy of homing sites may therefore exist in which BM has a
higher affinity than either fetal liver or spleen (Blair and Thomas,
1997). Under certain circumstances, however, the liver might 
take over the role of haematopoiesis (Tanigushi et al, 1996). It 
has furthermore (Cardier and Barbera-Guillem, 1997) been
demonstrated that specific liver sinusoidal EC can support
haematopoiesis, in analogy to BM culture.
The unique pathway that underlies the specific presence of MM
cells in this model is thus governed by a combination of multiple
factors. It is apparent that the first critical step is determined by the
presence or up-regulation of adhesion receptors on the MM cells
and their specific ligands on the luminal aspect of the EC lining the
BM vessels. Our in vitro adhesion assays presented here clearly
demonstrate the restricted adhesion to BM EC, similar to the
results obtained with progenitor cells (Imai et al, 1999). Several
reports describe the specific homing of progenitor cells to the BM
compartment. It has become clear that the migration of these pro-
genitors to the BM is restricted by adhesion mechanisms. For both
human and mouse lymphocytes and haematopoietic progenitors,
VCAM-1, which is expressed on the bone marrow vasculature,
serves as one of the main ligands for a4 integrins in the BM
(Frenette et al, 1998; Mazo et al, 1998; Berlin-Rufenach et al,
1999; Imai et al, 1999). It is likely that MM cells, which express
VLA-4 (a4b1) bind to VCAM-1 expressed on the BM EC during
adhesion to and passage through the endothelial barrier. Both in
vitro and in vivo experiments will be performed with the 5TMM
model in order to elucidate the role of VCAM-1 in the homing of
MM cells. Moreover, the local microenvironment is also assumed
to be involved in the up-regulation or the induction of conforma-
tional changes in, for example, the integrin expression. One class
of molecules responsible are the chemokines which bind to trans-
membranic G-protein-linked receptors triggering conformational
changes in leucocyte integrins resulting in a firm, stationary adhe-
sion, followed by leucocyte transmigration through inter-endothe-
lial junctions (Bianchi et al, 1997) or in some cases by
trans-endothelial migration (Feng et al, 1998). Once in the
extravascular compartment anti-apoptotic and growth stimulating
signals should be provided by the stromal microenvironment. In
vitro studies demonstrated the inhibition of apoptosis of a human
MM-derived cell line in the presence of BM stromal cells (Van
Riet et al, 1997). Interleukin 6 has furthermore been described as
one of the major survival and growth factors of MM in the BM
microenvironment (Kawano et al, 1988; Klein et al, 1989;
Uchiyama et al, 1993; Hardin et al, 1994; Juge-Morineau 
et al, 1995).
We conclude from the present study that the selective presence of
5T2MM cells in the BM and spleen is due to a combination of selec-
tive adhesion to vascular endothelium (followed by extravasation to
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the extravascular compartment), and of anti-apoptotic and mitogenic
signals. The local microenvironment in the BM probably has a
unique anti-apoptotic and growth stimulatory feature for the
5T2MM cells when compared to the liver. In the near future we will
try to identify these unique properties of the BM.
ACKNOWLEDGEMENTS
We thank Wendy Van de Voorde and Marijke Baekeland (Dept.
CYTO) for their excellent technical assistance. Dr. Yves St-Pierre
(Institut Armand Frappier, Laval, QC, Canada) and Dr. Radl
(Leiden, The Netherlands) are thanked for helpful discussions. The
work was financially supported by the Onderzoeksraad-Vrije
Universiteit Brussel (OZR-VUB), Fonds voor Wetenschappelijk
Onderzoek Vlaanderen (FWO-Vl), Vlaamse Liga tegen Kanker
and The International Myeloma Foundation (Brain Novis Award
1998). Karin Vanderkerken is a postdoctoral fellow and Isabelle
Vande Broek is a research assistant of FWO-Vl.
REFERENCES
Aoudjit F, Potworowski EF and St-Pierre Y (1998) The metastatic characteristics of
murine lymphoma cell lines in vivo are manifested after target organ invasion.
Blood 91: 623–629
Bakkus MH, Heirman C, Van Riet I, Van Camp B and Thielemans K (1992)
Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic
mutations but show no intraclonal variation. Blood 80: 2326–2335
Berlin-Rufenach C, Otto F, Mathies M, Westermann J, Owen MJ, Hamann A and
Hogg N (1999) Lymphocyte migration in lymphocyte function-associated
antigen (LFA-1)-deficient mice. J Exp Med 9: 1467–1478
Bianchi E, Bender JR, Blasi F and Pardi R (1997) Through and beyond the wall: late
steps in leukocyte transendothelial migration. Immunol Today 18: 586–591
Blair A and Thomas DB (1997) Preferential adhesion of fetal liver derived
primitive haemopoietic progenitor cells to bone marrow stroma. Br J
Haematol 99: 726–731
Butcher EC and Picker LJ (1996) Lymphocyte homing and homeostasis. Science
272: 60–66
Cardier JE and Barbera-Guillem E (1997) Extramedullary hematopoiesis in adult
liver is associated with specific sinusoidal endothelial cells. Hepatology 26:
165–175
Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM and Strober W (1984)
Induction and measurement of cytotoxic T lymphocyte activity. In: Current
Protocols in Immunology, Coico R (ed) pp. 3–11.14 Wiley Interscience
De Bleser P, Niki T, Rogiers V and Geerts A (1997) Transforming growth factor-b
gene expression in normal and fibrotic rat liver. J Hepatol 26: 886–893
Feng D, Nagy JA, Pyne K, Dvorak HF and Dvorak AM (1998) Neutrophils emigrate
from venules by a transendothelial cell pathway in response to FMLP. J Exp
Med 187: 903–915
Frenette PS, Subbarao S, Mazo IB, von Adrian UH and Wagner DD (1998)
Endothelial selectins and vascular cell adhesion molecule-1 promote
hematopietic progenitor homing to bone marrow. Proc Natl Acad Sci USA 95:
14423–14428
Hallek M, Bergsagel PL and Anderson KC (1998) Multiple myeloma: increasing
evidence for a multistep transformation process. Blood 91: 3–31
Hardin J, MacLeod S, Grigorieva I, Chang R, Barlogie B, Xiao H and Epstein J
(1994) Interleukin-6 prevents dexamathasone-induced myeloma cell death.
Blood 84: 3063–3070
Imai K and Kobayashi M (1998) Differences between bone marrow and lung
endothelial cells. Semin Thromb Hemostas 24: 275–277
Imai K, Kobayashi M, Wang J, Ohiro Y, Hamada JI, Cho Y, Imamura M, Musashi
M, Kondo T, Hosokawa M and Asaka M (1999) Selective transendothelial
migration of hematopoietic progenitor cells: a role in homing of progenitor
cells. Blood 93: 149–156
Jaeschke H and Smith CW (1997) Cell adhesion and migration. III. Leukocyte
adhesion and transmigration in the liver vasculature. Am J Physiol 273
(Gastrointest. Liver Physiol 36): G1169–1173
Jonas P, Holzmann B, Jablonski-Westrich D and Hamann A (1998) Dissemination
capacity of murine lymphoma cells is not dependent on efficient homing. Int J
Cancer 77: 402–407
Juge-Morineau N, Francois S, Puthier D, Godard A, Bataille R and Amiot M (1995)
The gp130 family cytokines IL-6, LIF and OSM but not IL-11 can reverse the
anti-proliferative effect of dexamethasone on human myeloma cells. Br J
Haematol 90: 707–710
Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B,
Tanabe O, Tanaka H, Kuramoto A and Kishimoto T (1988) Autocrine
generation and requirement of BSF-2/I1-6 for human multiple myelomas.
Nature 332: 83–85
Klein B, Zhang XG, Jourdan M, Content J, Houssiu F, Aarden L, Piechaczyk M and
Bataille R (1989) Paracrine rather than autocrine regulation of myeloma-cell
growth and differentation by interleukin-6. Blood 73: 517–526
Mazo IB, Gutierrez-Ramos JC, Frenette PS, Hynes RO, Wagner DD and von
Andrian UH (1998) Hematopoietic progenitor cell rolling in BM microvessels:
parallel contributions by endothelial selectins and vascular adhesion molecule
1. J Exp Med 188: 465–474
Pope B, Brown R, Gibson J and Joshua D (1997) Plasma cells in peripheral blood
stem cell harvest from patients with multiple myeloma are predominantly
polyclonal. Bone Marrow Transplant 20: 205–210
Radl J, De Glopper E, Schuit HRE and Zurcher C (1979) Idiopathic
paraproteinemia. II. Transplantation of the paraprotein-producing clone from
old to young C57BL/KaLwRij mice. J Immunol 122: 609–613
Salmi M, Adams D and Jalkanen S (1998) Cell adhesion and migration. IV.
Lymphocyte trafficking in the intestine and liver. Am J Physiol 274
(Gastrointest. Liver Physiol. 37): G1–G6
Smedsrod B and Pertoft H (1985) Preparation of pure hepatocytes and
reticuloendothelial cells in high yield from a single rat liver by means of
Percoll centrifugation and selective adherence. J Leukoc Biol 38: 213–230
Smith ME and Ford WL (1983) The recirculating lymphocyte pool of the rat: a
systematic description of the migratory behaviour of recirculating lymphocytes.
Immunology 49: 83–94
Tanigushi H, Toyoshima T, Fukao K and Nakauchi H (1996) Presence of
hematopoietic stem cells in the adult liver. Nat Med 2: 198–203
Tietz W and Hamann A (1997) The migratory behaviour of murine CD4+ cells of
memory phenotype. Eur J Immunol 27: 2225–2232
Uchiyama H, Barut KA, Mohrabacher AF, Chauchan D and Anderson KC (1993)
Adhesion of human myeloma-derived cell lines to bone marrow stromal cells
stimulates interleukin-6 seceretion. Blood 82: 3712–3720
Van Riet I, Heirman C, Lacor P, De Waele M, Thielemans K and Van Camp B
(1989) Detection of monoclonal B lymphocytes in bone marow and peripheral
blood of multiple myeloma patients by immunoglobulin gene rearrangements
studies. Br J Haematol 73: 289–295
Van Riet I, De Greef C, Aharchi F, Woischwill C, De Waele M, Bakkus M, Lacor P,
Schots R and Van Camp B (1997) Establishment and characterization of a
human stroma-dependent myeloma cell line (MM5.1) and its stroma-
independent variant (MM5.2). Leukemia 11: 284–293
Van Riet I, Vanderkerken K, De Greef C and Van Camp (1998) Homing behaviour
of the malignant cell clone in multiple myeloma. Medical Oncology 15:
154–164
Vanderkerken K, Goes E, De Raeve H, Radl J and Van Camp B (1996) Follow-up of
bone lesions in an experimental multiple myeloma mouse model: description of
an in vivo technique using radiography dedicated for mammography. Br J
Cancer 73: 1463–1465
Vanderkerken K, De Raeve H, Goes E, Van Meirvenne S, Radl J, Van Riet I,
Thielemans K and Van Camp B (1997) Organ involvement and phenotypic
adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij
mouse. Br J Cancer 76: 451–460
Vanderkerken K, Asosingh K, Braet F, Van Riet I and Van Camp B (1999) Insulin
like growth factor-1 acts as a chemoattractant factor for 5T2 multiple myeloma
cells. Blood 93: 235–241
Van Rooijen N (1989) The liposome-mediated ‘suicide’ technique. J Immunol
Methods 124: 1–6
Van Rooijen N and Sanders A (1996) Kupffer cell depletion by liposome-delivered
drugs: comparative activity by intracellular clodronate, propamidine, and
ethylenediaminetetraacetic acid. Hepatology 23: 1239–1243
Zhu D, Van Arkel C, King CA, Van Meirvenne S, De Greef C, Thielemans K, Radl J
and Stevenson K (1998) Immunoglobulin VH gene sequence analysis of
spontaneous murine immunoglobule-secreting B-cell tumors with clinical
features of human disease. Immunology 93: 162–170